Document:

Investment Agreement

Table of Contents

 Exhibit 10.2 
  

 
  

INVESTMENT AGREEMENT 
  

 
  

Table of Contents

 TABLE OF CONTENTS 

 

									
	ARTICLE I PURCHASE AND SALE OF SHARES; USE OF PROCEEDS 	  	 	1	  
				
		 	1.1	  	Agreement to Issue, Sell and Purchase the Shares	  	 	1	  
		 	1.2	  	Closing and Delivery of the Shares	  	 	1	  
		 	1.3	  	Use of Proceeds	  	 	2	  
		
	ARTICLE II REPRESENTATIONS AND WARRANTIES OF THE COMPANY 	  	 	2	  
				
		 	2.1	  	Organization and Qualification	  	 	2	  
		 	2.2	  	Authorized Capital Stock	  	 	2	  
		 	2.3	  	Issuance, Sale and Delivery of the Shares	  	 	3	  
		 	2.4	  	Due Execution, Delivery and Performance of the Agreement	  	 	3	  
		 	2.5	  	Valid Offering	  	 	4	  
		 	2.6	  	No Defaults	  	 	4	  
		 	2.7	  	No Material Change	  	 	4	  
		 	2.8	  	Compliance	  	 	5	  
		 	2.9	  	Litigation	  	 	5	  
		 	2.10	  	Transfer Taxes	  	 	6	  
		 	2.11	  	Investment Company	  	 	6	  
		 	2.12	  	Customers and Suppliers	  	 	6	  
		 	2.13	  	Corrupt Practices	  	 	6	  
		 	2.14	  	SEC Filings; Financial Statements	  	 	6	  
		 	2.15	  	Internal Accounting Controls	  	 	8	  
		 	2.16	  	Corporate Records	  	 	8	  
		 	2.17	  	Nasdaq Compliance and Listing	  	 	8	  
		 	2.18	  	Full Disclosure	  	 	8	  
		
	ARTICLE III REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE PURCHASERS 	  	 	9	  
				
		 	3.1	  	Investment Representations and Covenants	  	 	9	  
		 	3.2	  	Authorization; Validity of the Agreement	  	 	9	  
		 	3.3	  	No Conflict	  	 	9	  
		 	3.4	  	No Legal, Tax or Investment Advice	  	 	10	  

  
 -i- 

Table of Contents

									
		 	3.5	  	Restrictive Legend	  	 	10	  
		 	3.6	  	Sufficient Funds	  	 	10	  
		
	ARTICLE IV COVENANTS 	  	 	10	  
				
		 	4.1	  	Efforts	  	 	10	  
		 	4.2	  	Injunctive Relief	  	 	10	  
		 	4.3	  	Covenants	  	 	11	  
		 	4.4	  	Rights to Future Stock Issuances	  	 	11	  
		 	4.5	  	Lock-Up Agreement	  	 	13	  
		 	4.6	  	Nasdaq Matters	  	 	13	  
		 	4.7	  	Piggy-Back Registration Rights	  	 	13	  
		 	4.8	  	Public Announcements	  	 	13	  
		 	4.9	  	Reimbursement of Purchase Price; Repurchase of Shares	  	 	14	  
		
	ARTICLE V CONDITIONS TO THE CLOSING 	  	 	14	  
				
		 	5.1	  	Conditions to Each Party’s Obligation to Effect the Closing	  	 	14	  
		 	5.2	  	Conditions to Each Purchaser’s Obligation to Effect the Closing	  	 	14	  
		 	5.3	  	Conditions to the Company’s Obligation to Effect the Closing	  	 	15	  
		
	ARTICLE VI INDEMNIFICATION 	  	 	15	  
				
		 	6.1	  	Survival	  	 	15	  
		 	6.2	  	Limits on Claims	  	 	15	  
		 	6.3	  	Indemnification by the Company	  	 	16	  
		 	6.4	  	Indemnification by the Purchasers	  	 	16	  
		 	6.5	  	Procedure for Indemnification	  	 	16	  
		 	6.6	  	Remedies Exclusive	  	 	17	  
		 	6.7	  	Right of Set-Off	  	 	17	  
		
	ARTICLE VII MISCELLANEOUS 	  	 	17	  
				
		 	7.1	  	Broker’s Fee	  	 	17	  
		 	7.2	  	Assignment	  	 	17	  
		 	7.3	  	Expenses	  	 	17	  
		 	7.4	  	Notices	  	 	18	  
		 	7.5	  	Changes	  	 	18	  

  
 -ii- 

Table of Contents

									
		 	7.6	  	Headings	  	 	19	  
		 	7.7	  	Severability	  	 	19	  
		 	7.8	  	Governing Law	  	 	19	  
		 	7.9	  	Counterparts	  	 	19	  
		 	7.10	  	Entire Agreement	  	 	19	  
		 	7.11	  	No Third-Party Beneficiaries	  	 	19	  

  
 -iii- 

Table of Contents

 INVESTMENT AGREEMENT 

THIS INVESTMENT AGREEMENT (this “Agreement”) is made as of August 5, 2015, by and among Revolution Lighting Technologies,
Inc. (the “Company”), a corporation organized under the laws of the State of Delaware, with its principal offices at 177 Broad Street, 12th Floor, Stamford, CT 06901, Great
American Insurance Company, a corporation organized under the laws of the State of Ohio, with its principal offices at 301 East Fourth Street, Cincinnati, OH 45202 (“Great American”), Great American Life Insurance Company, a
corporation organized under the laws of the State of Ohio, with its principal offices at 301 East Fourth Street, Cincinnati, OH 45202 (“Great American Life”), and BFLT, LLC, an Ohio limited liability company
(“BFLT”, and together with Great American and Great American Life, the “Purchasers”). 
 IN CONSIDERATION
of the mutual covenants contained in this Agreement, the Company and the Purchasers agree as follows: 

ARTICLE I 

PURCHASE AND SALE OF SHARES; USE OF PROCEEDS 

1.1 Agreement to Issue, Sell and Purchase the Shares. At the Closing (as defined in
Section 1.2) and upon the terms and conditions hereinafter set forth, the Company will sell to: 
 (a) Great American, and Great
American will purchase from the Company, for an aggregate purchase price of Four Million Two Hundred Fifty Thousand Dollars ($4,250,000.00), 3,695,652 shares (the “Great American Shares”) of the Company’s Common Stock, par
value $0.001 per share (the “Common Stock”); 
 (b) Great American Life, and Great American Life will purchase from the
Company, for an aggregate purchase price of Four Million Two Hundred Fifty Thousand Dollars ($4,250,000.00), 3,695,652 shares (the “Great American Life Shares”) of Common Stock; and 

(c) BFLT, and BFLT will purchase from the Company, for an aggregate purchase price of One Million Five Hundred Thousand Dollars
($1,500,000.00), 1,304,348 shares (the “BFLT Shares” and together with the Great American Shares and the Great American Life Shares, the “Shares”) of Common Stock. 

1.2 Closing and Delivery of the Shares. 

(a) Closing. The purchase and sale of the Shares (the “Closing”) shall occur at the offices of Lowenstein Sandler LLP,
1251 Avenue of the Americas, New York, NY 10020, or such other place as the parties may agree, at 9:00 a.m., local time, upon three (3) Business Days’ written notice (the “Closing Notice”) from the Company to the
Purchasers stating that the conditions set forth in Article V hereof are expected to be satisfied or (to the extent permitted by Law) waived as of such date, and identifying such condition that is expected to be or has been waived (the
“Closing Conditions”). The obligations of the parties to consummate the Closing shall remain subject solely to the actual satisfaction or waiver of the Closing Conditions. The date on which the Closing occurs is referred to herein
as the “Closing Date”. Notwithstanding 

  
 -1- 

Table of Contents

 
anything to the contrary contained herein, the Closing shall occur no later than August 31, 2015 (the “Outside Date”). For purposes of this Agreement, the term
“Business Day” shall mean any day other than a Saturday, Sunday or a day on which the banks in New York, New York are authorized by Law (as defined in Section 2.8 ) or executive order to be closed. 

(b) Payment and Delivery of the Shares. At the Closing, the Company shall deliver to each Purchaser one or more stock certificates,
registered in the name of such Purchaser, or book-entry evidence of ownership, in either case representing the Shares set forth in Section 1.1 above and bearing the legend specified in Section 3.5 hereof referring to the fact
that the Shares were sold in reliance upon the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”) against delivery of the purchase price therefore by wire transfer
of immediately available funds to an account designated by the Company. 
 1.3 Use of Proceeds. Proceeds
from the sale of the Shares shall be used by the Company to pay a portion of the purchase price for the acquisition of Energy Source, LLC (the “Acquisition”) and for working capital purposes, if any proceeds remain after giving
effect to such acquisition. 
 ARTICLE II 

REPRESENTATIONS AND WARRANTIES OF THE COMPANY 

The Company hereby represents and warrants to, and covenants with, the Purchasers as follows: 

2.1 Organization and Qualification. The Company is a corporation duly organized, validly existing and in
good standing under the laws of the State of Delaware and the Company is qualified to do business as a foreign corporation in each jurisdiction in which such qualification is required, except where failure to be so qualified would not reasonably be
expected to result in a Material Adverse Effect (as defined in Section 2.7). Each Subsidiary is duly organized, validly existing and in good standing under the laws of its jurisdiction of formation and is qualified to do business as a
foreign entity in each jurisdiction in which such qualification is required, except where failure to be so qualified would not reasonably be expected to result in a Material Adverse Effect. Schedule 2.1 sets forth each direct or indirect
subsidiary of the Company (each a “Subsidiary” and collectively, the “Subsidiaries”). 
 2.2 
Authorized Capital Stock. As of the date hereof, the Company’s authorized capital stock consists of (i) 200,000,000 shares of Common Stock, of which 140,046,474 shares are issued and outstanding, and (ii) 5,000,000 shares of
preferred stock, par value $0.001 per share (the “Preferred Stock”), of which no shares are issued and outstanding. Except as set forth on Schedule 2.2, the Company has not issued any shares since March 31, 2015 other
than pursuant to employee or director equity incentive plans or purchase plans approved by the Board and upon the exercise or conversion of options, warrants and preferred stock outstanding on such date. The issued and outstanding shares of the
Company’s Common Stock have been duly authorized and validly issued, are fully paid and nonassessable, have been issued in compliance with all federal and state securities laws and were not issued in violation of or subject to any preemptive
rights or other rights to subscribe for or purchase securities. Except as set forth in 

  
 -2- 

Table of Contents

 
Schedule 2.2 or as contemplated by this Agreement, the Company does not have outstanding any options to purchase, or any preemptive rights or other rights to subscribe for or to purchase,
any securities or obligations convertible into, or any agreements or commitments to issue or sell, shares of capital stock or other securities of the Company and there are no agreements or commitments obligating the Company to repurchase, redeem, or
otherwise acquire capital stock or other securities of the Company. Except as set forth in Schedule 2.2 or as contemplated by this Agreement, there are no agreements to which the Company is a party or by which it is bound with respect to the
voting (including without limitation voting trusts or proxies), registration under the Securities Act, or sale or transfer (including without limitation agreements relating to pre-emptive rights, rights of first refusal, rights of first offer,
buy-sell rights, co-sale rights or “drag-along” rights) of any securities of the Company. With respect to each Subsidiary, (i) the Company owns (directly or through its direct Subsidiaries) 100% of each Subsidiary’s capital
stock, (ii) all the issued and outstanding shares of each such Subsidiary’s capital stock have been duly authorized and validly issued, are fully paid and nonassessable, have been issued in compliance with applicable federal and state
securities laws, and were not issued in violation of or subject to any preemptive rights or other rights to subscribe for or purchase securities, (iii) there are no outstanding options to purchase, or any preemptive rights or other rights to
subscribe for or to purchase, any securities or obligations convertible into, or any contracts or commitments to issue or sell, shares of any Subsidiary’s capital stock, and (iv) there are no agreements or commitments obligating any
Subsidiary of the Company to repurchase, redeem, or otherwise acquire capital stock or other securities of the Company or any such Subsidiary. The Company does not directly or indirectly own, or have a right to acquire, any equity or similar
interest in, or any interest convertible or exchangeable or exercisable for, any equity or similar interest in, any Person, other than the Subsidiaries. For purposes of this Agreement, the term “Person” shall mean any individual,
partnership, corporation, limited liability company, joint venture, association, joint-stock company, trust, unincorporated organization, government or agency or political subdivision thereof, or other entity. 

2.3 Issuance, Sale and Delivery of the Shares. The Shares will be, when issued, sold and delivered in
accordance with the terms hereof, duly authorized, validly issued, fully paid and nonassessable and shall be free and clear of all liens, claims, encumbrances and restrictions, except as imposed by applicable securities laws. No further approval or
authorization of the board of directors of the Company (the “Board of Directors” or the “Board”) will be required for the issuance, sale and delivery of the Shares to the Purchasers pursuant to the terms hereof.

 2.4 Due Execution, Delivery and Performance of the Agreement. The Company has full legal right,
corporate power and authority to authorize, execute and deliver this Agreement, perform its obligations hereunder and consummate the transactions contemplated hereby. The execution and delivery of this Agreement, the performance of the
Company’s obligations hereunder and the consummation of the transactions contemplated hereby have been duly authorized by the Company. The execution and performance of this Agreement by the Company and the consummation of the transactions
herein contemplated will not (i) violate any provision of the organizational documents of the Company, (ii) result in the creation of any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, restriction, adverse
claim, interference or right of third party of any nature upon any material assets of the Company pursuant to the terms or provisions of, or will not conflict with, result in the breach or violation of, or constitute, either by itself or upon notice
or the passage of time or both, a default under, 

  
 -3- 

Table of Contents

 
any material agreement, commitment, undertaking, mortgage, deed of trust, lease, franchise, license, indenture, permit or other instrument of any nature to which the Company or any Subsidiary is
a party or by which the Company or its properties, or any Subsidiary or any Subsidiary’s properties, may be bound or affected, or (iii) violate any statute or any authorization, judgment, decree, order, rule or regulation of any court or
any regulatory body, administrative agency or other governmental or quasi-governmental body applicable to the Company or any Subsidiary or any of their respective properties. No consent, approval, authorization, order, filing with, or action by or
in respect of any court, regulatory body, administrative agency or other governmental or quasi-governmental body is required for the execution and delivery of this Agreement or the consummation of the transactions contemplated hereby, other than
such as have been made or obtained and except for compliance with state securities Laws, federal securities Laws and NASDAQ rules applicable to the listing of the Shares. Upon their execution and delivery, and assuming the valid execution thereof by
the Purchasers, this Agreement will constitute the valid and binding obligations of the Company, enforceable in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or
similar laws affecting creditors’ and contracting parties’ rights generally and except as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or
at law). 
 2.5 Valid Offering. Assuming the accuracy of the representations and warranties of
Purchasers set forth in Article III, the offer, sale, and issuance of the Shares will be exempt from the registration requirements of the Securities Act and will have been registered or qualified (or are exempt from registration and
qualification) under the registration or qualification requirements of all applicable state securities Laws. Neither the Company nor any Person acting on its behalf will knowingly take any action that would cause the loss of any such exemption. 

2.6 No Defaults. The Company is not in violation or default of any provision of its certificate of
incorporation or bylaws, or other organizational documents, except as to defaults, violations and breaches which, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect; and, to the knowledge of the
Company there does not exist any state of fact which, with notice or lapse of time or both, would constitute a breach or default on the part of the Company, except such breaches or defaults which individually or in the aggregate would not reasonably
be expected to have a Material Adverse Effect. 
 2.7 No Material Change. Since March 31, 2015,
and except for the matters set forth on Schedule 2.7, (i) neither the Company nor any Subsidiary has incurred any material liabilities or obligations which would be required under generally accepted accounting principles in the United
States (“GAAP”) to be set forth on the Company’s balance sheet; (ii) neither the Company nor any Subsidiary has sustained any material loss or interference with its respective businesses or properties from fire, flood,
windstorm, accident or other calamity whether or not covered by insurance; (iii) the Company has not paid, authorized or declared any dividends or other distributions with respect to its capital stock, or redeemed or repurchased any securities
of the Company; (iv) neither the Company nor any Subsidiary is in default in the payment of principal or interest on any outstanding debt obligations; (v) there has not been any change, by split, combination, reclassification or otherwise,
in the capital stock of the Company or, other than the sale of the Shares hereunder and the issuance of shares or options pursuant to employee 

  
 -4- 

Table of Contents

 
or director equity incentive plans or purchase plans approved by the Board of Directors or upon the exercise of options and warrants outstanding on such date, the issuance, sale or other
disposition of any shares of capital stock of the Company, (vi) there has not been any waiver, not in the ordinary course of business, by the Company or any Subsidiary of a material right or of a material debt owed to it; (vii) there has
not been any satisfaction or discharge of any lien, claim or encumbrance or payment of any obligation by the Company or any Subsidiary, except in the ordinary course of business and which is not material to the assets (including intangible assets),
properties, condition (financial or otherwise), operations or results of operations or business of the Company and the Subsidiaries taken as a whole; (viii) there has not been any change or amendment to the Company’s certificate of
incorporation or bylaws, or material change to any material contract or arrangement by which the Company or any Subsidiary is bound or to which any of their respective assets or properties is subject; (ix) there has not been any contract or
transaction entered into by the Company or any Subsidiary other than in the ordinary course of business; (x) there has not been the loss or threatened loss of any material customer; (xi) there has not been the incurrence of any lien upon
any of the Company’s properties, capital stock or assets, tangible or intangible; and (xii) there have been no events or occurrences which, individually or in the aggregate, have had or would reasonably be expected to have a Material
Adverse Effect. For purposes of this Agreement, the term “Material Adverse Effect” shall mean: (a) a material adverse effect on the condition (financial or otherwise), properties, assets (including intangible assets), business,
operations or results of operations of the Company and the Subsidiaries, taken as a whole, or (b) a material adverse effect on the ability of the Company to perform its obligations under this Agreement. 

2.8 Compliance. Each of the Company and the Subsidiaries has complied with each Law and is not in
violation of any such Law. There have been no written notices or orders of material noncompliance issued to the Company or any Subsidiary under or in respect of any such Law and, to the knowledge of the Company, none of the Company or any Subsidiary
is or has been charged or under investigation with respect to any material noncompliance. To the knowledge of the Company, there are no existing circumstances that are reasonably likely to result in any such violation. “Law” means
any judgment, ruling, order, edict, decree, statute, law (including common law), ordinance, rule, permit, code or regulation applicable to the Company or any Subsidiary or their respective businesses, properties or assets. 

2.9 Litigation. Except as set forth in Schedule 2.9, there is no action, suit, proceeding, claim,
arbitration, mediation or investigation pending, or, to the Company’s knowledge, threatened, before any regulatory body, agency, court, tribunal or governmental or quasi-governmental entity, foreign or domestic (“Governmental
Entity”), against or affecting the Company or any Subsidiary. Except as set forth in Schedule 2.9, neither the Company nor any Subsidiary has received any notice or assertion of such an action, suit, proceeding, claim, arbitration,
mediation or investigation. To the knowledge of the Company, there is no reasonable basis for any such action, suit, proceeding, claim, arbitration, mediation or investigation except for the matters set forth on Schedule 2.9, or for any
Person to assert a claim against the Company or any Subsidiary based upon the Company entering into this Agreement, performing its obligations hereunder or consummating the transactions contemplated hereby. There is no judgment, decree, writ, award,
temporary or permanent injunction, stipulation, determination or order against the Company or any Subsidiary or any of their respective officers (in their capacities as such), or any of their respective properties or assets, or, to the knowledge of
the 

  
 -5- 

Table of Contents

 
Company, any of the Company’s employees (in their capacities as such). There are no settlements or similar agreements with any Governmental Entity affecting the Company or any Subsidiary or
any of their respective properties or assets. None of the Company or any Subsidiary has any actions, suits, proceedings, claims, arbitrations, mediations or investigations pending before any regulatory body, agency, court, tribunal or governmental
or quasi-governmental body against any other Person, nor is the Company or any Subsidiary a party to, or subject to the provisions of, any judgment, decree, writ, award, temporary or permanent injunction, stipulation, determination or order of any
Governmental Entity. 
 2.10 Transfer Taxes. Prior to the issuance of the Shares, all stock transfer or
other taxes (other than income taxes) which are required to be paid in connection with such sale and issuance will be, or will have been, fully paid or provided for by the Company, all Laws imposing such taxes will be or will have been fully
complied with, and all tax returns with respect to such taxes will be timely filed. 
 2.11 Investment
Company. The Company is not an “investment company” or an “affiliated person” of, or “promoter” or “principal underwriter” for an investment company, within the meaning of the Investment Company Act of
1940, as amended. 
 2.12 Customers and Suppliers. Since March 31, 2015, no significant customer
or supplier of the Company or any Subsidiary, including but not limited to any state or federal agency, has given the Company or any Subsidiary any written notice terminating, suspending, or reducing in any material respect, or specifying an
intention to terminate, suspend, or reduce in any material respect in the future, or otherwise reflecting a material adverse change in, the business relationship between such customer or supplier and the Company or any Subsidiary, and, there has not
been any materially adverse change in the business relationship of the Company or any Subsidiary with any such customer or supplier since March 31, 2015. 

2.13 Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company, any
agent or other person acting on behalf of the Company or any Subsidiary, has (i) directly or indirectly, used any corporate funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic
political activity, (ii) directly or indirectly, made any unlawful payment to any foreign or domestic government officials or employees or to foreign or domestic political parties or campaigns from corporate funds, (iii) established or
maintained any unlawful or unrecorded fund of corporate monies or other assets, (iv) made any false or fictitious entries on the book and records of the Company, (v) failed to disclose fully any contribution made by the Company or any
Subsidiary or made by any person acting on its behalf and of which the Company is aware in violation of Law, or (vi) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as amended. 

2.14 SEC Filings; Financial Statements. 

(a) The Company’s Common Stock is registered pursuant to Section 12(b) of the Securities and Exchange Act of 1934, as amended (the
“Exchange Act”) and the Company has filed all forms, reports and documents required to be filed with the SEC since January 1, 2013, all of which are available to the Purchasers on the website maintained by the SEC at

  
 -6- 

Table of Contents

 
http://www.sec.gov (the “SEC Website”). All such required forms, reports and documents (including those that the Company may file subsequent to the date hereof) are referred
to herein collectively as the “Company SEC Reports”. In addition, all documents filed as exhibits to the Company SEC Reports (“Exhibits”) are available on the SEC Website. All documents required to be filed as
Exhibits to the Company SEC Reports have been so filed. As of their respective filing dates, the Company SEC Reports (i) complied in all material respects with the requirements of the Securities Act or the Exchange Act, as the case may be, and
the rules and regulations of the SEC thereunder applicable to such Company SEC Reports, and (ii) did not at the time they were filed (or if amended or superseded by a subsequent filing prior to the date of this Agreement, then on the date of
such subsequent filing) contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were
made, not misleading. The Company is engaged only in the business described in the Company SEC Reports, and the Company SEC Reports contain a complete and accurate description in all material respects of the Company’s and the Subsidiaries’
business. 
 (b) Each of the consolidated financial statements (including, in each case, any related notes thereto) contained in the
Company SEC Reports (the “Company Financials”), (i) complied or will comply as to form in all material respects with applicable accounting requirements and with the published rules and regulations of the SEC with respect
thereto as of their respective dates, (ii) was or will be prepared in accordance with GAAP applied on a consistent basis throughout the periods involved and consistent with each other (except as may be indicated in the notes thereto or, in the
case of unaudited interim financial statements, as may be permitted by the SEC on Form 10-Q under the Exchange Act) and (iii) fairly presented in all material respects the consolidated financial position of the Company and the Subsidiaries as
at the respective dates thereof and the consolidated results of operations and cash flows for the periods indicated, except that the unaudited interim financial statements were or are reasonably expected to be subject to normal and recurring
year-end adjustments. Since January 1, 2015, there has been no material change in the Company’s accounting policies except as described in the notes to the Company Financials. The balance sheet of the Company contained in the Company SEC
Report for the quarter ended March 31, 2015, is hereinafter referred to as the “Company Balance Sheet.” Except as set forth on Schedule 2.14(b), neither the Company nor any Subsidiary has incurred any obligations or
liabilities (absolute, accrued, contingent or otherwise) of any nature required to be disclosed on a balance sheet or in the related notes to the consolidated financial statements prepared in accordance with GAAP which are, individually or in the
aggregate, material to the business, operations, results of operations or condition (financial or otherwise) of the Company and the Subsidiaries taken as a whole, except liabilities (i) reflected on, reserved against, or disclosed in the notes
to the Company Balance Sheet, or (ii) incurred since the date of the Company Balance Sheet in the ordinary course of business consistent with past practice. 

(c) The Company has heretofore made available to the Purchasers complete and correct copies of any amendments or modifications, which have not
yet been filed with the SEC but which are required to be filed, to agreements, documents or other instruments which previously had been filed by the Company with the SEC pursuant to the Securities Act or the Exchange Act. 

  
 -7- 

Table of Contents

 2.15 Internal Accounting Controls. The Company maintains a
system of internal accounting controls sufficient to provide reasonable assurances that (i) transactions are executed in accordance with management’s general or specific authorization; (ii) transactions are recorded as necessary to
permit preparation of financial statements in conformity with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the
recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company has disclosure controls and procedures (as defined in Rules 13a-14 and 15d-14
under the Exchange Act) that are designed to ensure that material information relating to the Company is made known to the Company’s principal executive officer and the Company’s principal financial officer or persons performing similar
functions. The Company is in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley Act of 2002 (the “Act”). Each of the principal executive officer and the principal financial officer of the
Company (or each former principal executive officer and former principal financial officer of the Company, as applicable) has made all certifications required under Sections 302 and 906 of the Act and the related rules and regulations promulgated
thereunder. 
 2.16 Corporate Records. The Company has delivered or made available to Purchasers true
and complete copies of the certificate of incorporation and bylaws (in each case as amended to the date of this Agreement) of the Company and the certificate of incorporation and bylaws (or other comparable organization or governance documents) of
each Subsidiary. Except as set forth on Schedule 2.16, the minute books of the Company and the Subsidiaries previously made available to Purchasers contain complete and accurate minutes of all meetings of the Board of Directors and the board
of directors of each Subsidiary (and all committees thereof) ratified as of the date hereof and accurately reflect all other corporate action of the stockholders of the Company, the Board of Directors and the board of directors of each Subsidiary
(and all committees thereof) to the date hereof, including all amendments and corrections. Schedule 2.16 sets forth minutes from prior meetings of the Board of Directors (and the audit committee thereof) which minutes have not yet been
approved by the Board of Directors (or the audit committee, as the case may be) but which are substantially complete and accurately reflect, in all material respects, the corporate action of the Board of Directors (or the audit committee, as the
case may be) taken at such meetings. 
 2.17 Nasdaq Compliance and Listing. The Company’s Common
Stock is listed on the NASDAQ Stock Market. The Company has taken no action designed to, or likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act or delisting the Common Stock from the NASDAQ Stock
Market. No order ceasing or suspending trading in any securities of the Company or prohibiting the issuance and/or sale of the Shares is in effect and no proceedings for such purpose are pending or threatened. The Company is in compliance with the
continued listing requirements and standards of the NASDAQ Stock Market with respect to the Common Stock. The Company shall comply with all requirements of the Financial Industry Regulatory Authority, Inc. with respect to the issuance of the Shares.

 2.18 Full Disclosure. No representation or warranty by the Company in this Agreement and
no statement contained in the Schedules to this Agreement contains any untrue statement of a material fact, or omits to state a material fact necessary to make the statements contained therein, in light of the circumstances in which they are
made, not misleading. 

  
 -8- 

Table of Contents

 ARTICLE III 

REPRESENTATIONS, WARRANTIES AND COVENANTS OF THE PURCHASERS 

Each of the Purchasers hereby represents and warrants to, and covenants with, the Company as follows: 

3.1 Investment Representations and Covenants. The Purchaser represents and warrants to, and covenants
with, the Company that: (i) the Purchaser is knowledgeable, sophisticated and experienced in making, and is qualified to make, decisions with respect to investments in securities including the Shares; (ii) the Purchaser is acquiring the
number of Shares set forth in Section 1.1 above in the ordinary course of its business and for its own account for investment only and with no present intention of distributing any of such Shares or any arrangement or understanding with
any other persons regarding the distribution of such Shares within the meaning of Section 2(a)(11) of the Securities Act; (iii) the Purchaser will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or
solicit any offers to buy, purchase or otherwise acquire or take a pledge of) any of the Shares except in compliance with the Securities Act, applicable state securities laws and the respective rules and regulations promulgated thereunder; and
(iv) the Purchaser is an “accredited investor” within the meaning of Rule 501 of Regulation D promulgated under the Securities Act. The Purchaser understands that its acquisition of the Shares has not been registered under the
Securities Act or registered or qualified under any state securities laws in reliance on specific exemptions therefrom, which exemptions may depend upon, among other things, the bona fide nature of the Purchaser’s investment intent as expressed
herein. 
 3.2 Authorization; Validity of the Agreement. The Purchaser further represents and warrants
to, and covenants with, the Company that (i) the Purchaser has full right, power, authority and capacity to enter into this Agreement and to consummate the transactions contemplated hereby and has taken all necessary action to authorize the
execution, delivery and performance of this Agreement, and (ii) upon the execution and delivery of this Agreement, assuming the valid execution hereof by the Company, this Agreement shall constitute valid and binding obligations of the
Purchaser enforceable in accordance with its terms, except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or similar laws affecting creditors’ and contracting parties’ rights generally and
except as enforceability may be subject to general principles of equity (regardless of whether such enforceability is considered in a proceeding in equity or at law). 

3.3 No Conflict. The execution, delivery and performance of this Agreement and the consummation of the
transactions contemplated hereby by the Purchaser will not result in any violation of, be in conflict with or constitute a default under, any law, statute, regulation, ordinance, material contract or agreement, instrument, judgment, decree or order
to which the Purchaser is a party or by which it is bound, except as would not reasonably be expected to have a material adverse effect on the ability of Purchaser to consummate the transactions contemplated hereby. 

  
 -9- 

Table of Contents

 3.4 No Legal, Tax or Investment Advice. The Purchaser
understands that nothing in this Agreement, the Company SEC Reports or any other materials presented to the Purchaser in connection with the purchase and sale of the Shares constitutes legal, tax or investment advice. The Purchaser has consulted
such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Shares. The Purchaser acknowledges that it has not relied on any representation or warranty from the
Company or any other Person in making its investment or decision to invest in the Company, except as expressly set forth in this Agreement. 

3.5 Restrictive Legend. The Purchaser understands that, until such time as a registration statement
covering the Shares has been declared effective or the Shares may be sold pursuant to Rule 144 under the Securities Act without any restriction as to the number of securities as of a particular date that can then be immediately sold, the Shares
shall bear a restrictive legend in substantially the following form (and a stop-transfer order may be placed against transfer of the certificates for the Shares): 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SECURITIES MAY
NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR AN OPINION OF COUNSEL, IN FORM, SUBSTANCE AND SCOPE REASONABLY ACCEPTABLE TO THE COMPANY, THAT REGISTRATION IS NOT
REQUIRED UNDER SAID ACT OR UNLESS SOLD PURSUANT TO RULE 144 UNDER SAID ACT.” 
 3.6 Sufficient
Funds. The Purchaser has sufficient funds to consummate the purchase of the Shares. 
 ARTICLE IV

 COVENANTS 
 4.1
Efforts. At and from time to time after the Closing, at the request of any party hereto, the other party shall execute and deliver such additional certificates, instruments, and other documents and take such
other actions as such party may reasonably request in order to carry out the purposes of this Agreement. 
 4.2 
Injunctive Relief. Each party acknowledges that any breach or threatened breach of the provisions of Section 4.4 of this Agreement will cause irreparable injury to the other party for which an adequate monetary remedy does not
exist. Accordingly, in the event of any such breach or threatened breach, the non-breaching party shall be entitled, in addition to the exercise of other remedies, to seek and (subject to court approval) obtain injunctive relief, without necessity
of posting a bond, restraining the breaching party from committing such breach or threatened breach. The right provided under this Section 4.2 shall be in addition to, and not in lieu of, any other rights and remedies available to the
parties. 

  
 -10- 

Table of Contents

 4.3 Covenants. Each party hereto shall promptly inform the
other party of any communication from any Governmental Entity regarding any of the transactions contemplated by this Agreement. If any party or affiliate thereof receives a request for additional information or documentary material from any such
Governmental Entity in respect of the transactions contemplated hereby, then such party will endeavor in good faith to make, or cause to be made, as soon as reasonably practicable and after consultation with the other party, an appropriate response
in compliance with such request. 
 4.4 Rights to Future Stock Issuances. 

(a) Right of First Offer. Subject to the terms and conditions of this Agreement, including this Section 4.4, and applicable
securities laws, if, during the Lock-Up Period (as defined in Section 4.5), the Company proposes to offer or sell (a “New Equity Offering”) any shares of Common Stock or other equity securities of the Company, whether or
not currently authorized, or any other securities of any type whatsoever that are, or may become, with or without the payment of consideration, convertible or exchangeable into or exercisable for equity securities of the Company (collectively, the
“New Securities”), the Company shall first offer such New Securities (the “Right of First Offer”) to each Purchaser (each, a “ROFO Purchaser”). 

(i) The Company shall give notice (the “Offer Notice”) to each ROFO Purchaser, stating (i) its bona fide
intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such New Securities. 

(ii) By notification to the Company within ten (10) days after the Offer Notice is given, each ROFO Purchaser may elect to
purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the respective number of Shares issued to such ROFO Purchaser at the Closing bears
to the total number of Shares issued to all Purchasers at the Closing. The closing of any sale pursuant to this Section 4.4(a)(ii) shall occur by the earlier of thirty (30) days of the date that the Offer Notice is given and the
date of initial sale of New Securities pursuant to Section 4.4(a)(iii). 
 (iii) If all New Securities referred
to in the Offer Notice are not elected to be purchased or acquired as provided in Section 4.4(a)(ii), the Company may, during the one hundred twenty (120) day period following the expiration of the periods provided in
Section 4.4(a)(ii), offer and sell the remaining unsubscribed portion of such New Securities (subject to the RVL 1 Offer Right (as defined below)) to any Person or Persons at a price not less than, and upon terms no more favorable to the
offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not consummated within sixty (60) days of the execution thereof,
the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the ROFO Purchasers in accordance with this Section 4.4(a). 

  
 -11- 

Table of Contents

 (iv) The parties acknowledge that the Company has previously granted a right of
first offer with respect to the issuance of new equity securities to RVL 1 LLC (the “RVL 1 Offer Right”) pursuant to the Investment Agreement, dated as of September 12, 2012, by and between Nexxus Lighting, Inc. (as predecessor
to the Company) and RVL 1 LLC. In the event of any conflict between the relative priority of the Right of First Offer hereunder and the RVL 1 Offer Right, the RVL 1 Offer Right shall be subordinated to the Right of First Offer. Accordingly, upon any
New Equity Offering, the Company shall first comply with the terms of this Section 4.4; thereafter, to the extent that any portion of the New Securities in the New Equity Offering are not elected to be purchased or acquired as provided
in Section 4.4(a)(ii), the Company shall then comply with its obligations pursuant to the RVL 1 Offer Right with respect to such unsubscribed portion. On or prior to the Closing, the Company shall deliver to the Purchasers an
acknowledgement of RVL 1 LLC to this Section 4.4(a)(iv), and a waiver of the RVL 1 Offer Right in connection with the sale of the Shares pursuant to this Agreement. 

(b) Termination of Right of First Offer. The covenants set forth in this Section 4.4 shall terminate and be of no further
force or effect upon the earliest to occur of (x) the expiration of the Lock-Up Period, or (y) a Change of Control (as defined in Section 4.5). For the avoidance of doubt, the Company shall have no obligation to make any Right
of First Offer to the Purchasers pursuant to this Section 4.4 until the Lock-Up Period shall have commenced in accordance with Section 4.5. 

(c) Exempt Securities Issuance. Notwithstanding anything contained herein to the contrary, the Right of First Offer in this
Section 4.4 shall not be applicable to any Exempt Securities Issuance. For purposes of this Agreement, an “Exempt Securities Issuance” shall mean the issuance of any equity securities of the Company (i) under an
equity incentive plan approved by the affirmative vote of a majority of the members of the Board, including the Company’s 2013 Stock Incentive Plan (as amended or modified from time to time); (ii) to financial institutions or lessors in
connection with commercial credit arrangements, equipment financing or similar transactions; (iii) to third Persons as a component of any business relationship with such Person for purposes of (A) joint venture, technology licensing or
development activities, (B) distribution, supply or manufacture of the Company’s products or services or (C) any other arrangements involving corporate partners that are primarily for purposes other than raising capital; (iv) as
consideration in connection with the acquisition of another corporation or entity by the Company by consolidation, merger, purchase of all or substantially all of the assets, or other reorganization in which the Company acquires, in a single
transaction or series of related transactions, all or substantially all of the assets of such other corporation or entity or fifty percent (50%) or more of the voting power of such other corporation or entity or fifty percent (50%) or more
of the equity ownership of such other entity; (v) pursuant to any split, reverse split, dividend, recapitalization, combination or reclassification of any capital stock of the Company without the receipt of consideration by the Company;
(vi) pursuant to the conversion or exercise of convertible or exercisable securities; or (vii) in a sale to the public in an offering pursuant to an effective registration statement under the Securities Act. 

  
 -12- 

Table of Contents

 (d) Waiver of Right of First Refusal. Notwithstanding anything contained herein to the
contrary, (x) any ROFO Purchaser may, by written notice to the Company, waive such ROFO Purchaser’s right to exercise such ROFO Purchaser’s Right of First Offer with respect to any New Equity Offering; provided, however,
that any such waiver shall be irrevocable unless all of the other Purchasers and the Company, in their sole discretion, determine otherwise, and (y) the Purchasers may together, by written notice to the Company, waive the rights of all ROFO
Purchasers to exercise their Right of First Offer with respect to any New Equity Offering. 
 4.5 Lock-Up
Agreement. Except in connection with a Change of Control (as defined below), the Purchasers shall not, without prior written approval of the Company, directly or indirectly, sell, offer or agree to sell, contract to sell, grant any option for
the sale of, make any short sale, pledge, or enter into any hedging transaction that could result in a transfer of, or otherwise dispose of the Shares for a period commencing as of the Closing Date and ending on the six (6) month anniversary of
the Closing Date (the “Lock-Up Period”). For purposes of this Agreement, a “Change of Control” shall mean (x) the consummation of any of the following transactions: (i) the sale, lease, exchange,
conveyance or other disposition of all or substantially all of the Company’s property or business, (ii) the merger of the Company into or its consolidation with any other entity in which the Company is not the surviving entity (other than
a wholly-owned subsidiary of the Company) or (iii) any transaction (including a merger or other reorganization) or series of related transactions, in which more than 50% of the voting power of the Company is disposed of; or (y) individuals
who, immediately after giving effect to the Closing, constitute the Board (the “Incumbent Directors”) cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to
such date, whose election or nomination for election was approved by a vote of at least a majority of the Incumbent Directors then on the Board (either by a specific vote or by approval of the proxy statement of the Company in which such person is
named as a nominee for director) shall be an Incumbent Director. 
 4.6 Nasdaq Matters. The Company
shall comply with all requirements of the Financial Industry Regulatory Authority, Inc. with respect to the issuance of the Shares. The Company shall take all necessary actions, including without limitation, complying with all requirements of the
Financial Industry Regulatory Authority, Inc. and providing appropriate notice to NASDAQ with respect to the Shares in order to obtain the listing of the Shares on the NASDAQ Stock Market as soon as reasonably practicable. 

4.7 Piggy-Back Registration Rights. Simultaneously with the execution of this Agreement, the
Company and the Purchasers shall enter into a Registration Rights Agreement in the form attached hereto as Annex A (the “Registration Rights Agreement”), granting the Purchasers “piggy-back” registration rights with
respect to the Shares. 
 4.8 Public Announcements. The Company and the Purchasers will consult
with each other and will mutually agree (the agreement of each party not to be unreasonably withheld) upon the content and timing of any press release or other public statement in respect of the transactions contemplated hereby and shall not issue
any such press release or make any such public statement prior to such consultation and agreement, except as may be required by applicable law or stock exchange regulation, provided any such press release or other public announcement shall not
contain the name of any Purchaser unless required by applicable law or unless consented in writing by such Purchaser. 

  
 -13- 

Table of Contents

 4.9 Reimbursement of Purchase Price; Repurchase of Shares.
In the event that the Closing shall have occurred, and either (i) the Membership Interest Purchase Agreement (as defined in Section 5.1) shall have been terminated in accordance with its terms or (ii) the closing of the
Acquisition shall not have occurred prior to the Outside Date, the Company hereby agrees that it shall promptly (but in no event later than two (2) Business Days following the occurrence of the events specified in clauses (i) or (ii), as
the case may be) repurchase the Shares from the Purchasers for the full dollar amount paid by the Purchasers at the Closing as set forth in Section 1.1. 

ARTICLE V 

CONDITIONS TO THE CLOSING 

5.1 Conditions to Each Party’s Obligation to Effect the Closing. The respective obligations of the
Company and the Purchasers to effect the Closing shall be subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to the Closing Date of the following conditions: 

(a)(x) All conditions precedent to the closing of the transactions contemplated by that certain Membership Interest Purchase Agreement, dated
as of the date hereof, by and among Revolution Lighting Technologies – Energy Source, Inc., a wholly-owned subsidiary of the Company, Energy Source, LLC and the sellers party thereto (the “Membership Interest Purchase
Agreement”) shall have been satisfied or waived (to the extent permitted by Law); (y) a duly authorized officer of the Company shall have delivered a certified Closing Notice to the Purchasers; and (z) the Chief Executive Officer,
the President or the Chief Financial Officer of the Company shall have certified to the Purchasers that the Company has received wire transfer instructions to transfer payment for its funding obligations as required pursuant to Membership Interest
Purchase Agreement, which the Company shall execute immediately following receipt of funding from the Purchasers. 
 5.2 
Conditions to Each Purchaser’s Obligation to Effect the Closing. The obligations of each Purchaser to purchase and pay for the Shares shall be subject to the satisfaction (or waiver, if permissible under applicable Law) on or prior to
the Closing Date of the following conditions: 
 (a) Each of the representations and warranties of the Company contained in Article II
hereof shall be true and correct in all material respects on and as of the date hereof (provided, however, that such qualification shall only apply to representations and warranties not otherwise qualified by materiality) and on and as of the
Closing Date (or, if given as of a specific date, at and as of such date) with the same effect as though such representations and warranties had been made as of the Closing, except where the failure to be so true and correct has not had, and would
not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

  
 -14- 

Table of Contents

 (b) The Company shall have performed and complied in all material respects with all covenants,
agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the Company on or before the Closing. 

(c) The Company will have delivered to the Purchasers a certificate signed on its behalf by a duly authorized officer certifying that the
conditions specified in Sections 5.2(a) and 5.2(b) hereof have been fulfilled. 
 5.3
Conditions to the Company’s Obligation to Effect the Closing. The obligations of the Company to sell the Shares to the Purchasers shall be subject to the satisfaction (or waiver, if permissible under
applicable Law) on or prior to the Closing Date of the following conditions: 
 (a) Each of the representations and warranties of each
Purchaser contained in Article III hereof shall be true and correct in all material respects on and as of the date hereof (provided, however, that such qualification shall only apply to representations and warranties not otherwise
qualified by materiality) and on and as of the Closing Date with the same effect as though such representations and warranties had been made as of the Closing. 

(b) The Purchasers shall have performed and complied with all covenants, agreements, obligations and conditions contained in this Agreement
that are required to be performed or complied with by them on or before the Closing. 
 ARTICLE VI 

INDEMNIFICATION 
 6.1 
Survival. The representations and warranties contained herein or in any certificate or other writing delivered pursuant hereto or in connection herewith shall survive the Closing until the eighteen (18) month anniversary of the Closing
and any investigation or finding made by or on behalf of a Purchaser or the Company; provided that the representations and warranties in Sections 2.1, 2.2, 2.3, and 2.4 shall survive indefinitely or until the
latest date permitted by law. The covenants and agreements contained herein or in any certificate or other writing delivered pursuant hereto or in connection herewith shall survive the Closing indefinitely or for the shorter period explicitly
specified herein or therein. Notwithstanding the preceding sentences, any breach of representation, warranty, covenant or agreement in respect of which indemnity may be sought under this Agreement shall survive the time at which it would otherwise
terminate pursuant to the preceding sentences, if written notice of the inaccuracy or breach thereof giving rise to such right of indemnity shall have been given to the party against whom such indemnity may be sought prior to such time. 

6.2 Limits on Claims. The Company’s indemnification obligations under this Agreement shall be
subject to the following: 
 (a) The Company shall have no obligation to indemnify or hold harmless the any Purchaser unless, and only to the
extent that, the aggregate amount of Losses (as defined in Section 6.3) incurred by the Purchasers exceeds $50,000, in which event the Company shall be required to pay or be liable for all such Losses from the first dollar; and 

  
 -15- 

Table of Contents

 (b) The Company shall have no obligation to make indemnification payments hereunder that exceed
the aggregate of the purchase price paid for the Shares by all Purchasers as set forth in Section 1.1. 
 In determining the foregoing
thresholds and in otherwise determining the amount of any Losses for which a party is entitled to assert a claim for indemnification hereunder, the amount of any such Losses shall be determined disregarding any materiality or similar qualifiers
contained in this Agreement or in any other certificate or writing delivered pursuant to this Agreement. 
 6.3 
Indemnification by the Company. From and after the Closing Date, subject to any applicable limitations set forth in Section 6.1 and Section 6.2, the Company shall indemnify and hold each Purchaser and its affiliates,
and their respective officers, directors, stockholders, partners, managers, members, employees, agents, and representatives (collectively, the “Purchaser Indemnified Parties”) harmless from and against all claims, liabilities,
obligations, costs, damages, losses and expenses (including reasonable attorneys’ fees) of any nature (each a “Loss” and collectively, “Losses”) arising out of or relating to any breach or violation of the
representations, warranties, covenants or agreements of the Company set forth in this Agreement or in any other certificate or writing delivered by the Company pursuant to this Agreement (in each case disregarding for this purpose any materiality,
Material Adverse Effect or similar qualifiers contained herein or therein). 
 6.4 Indemnification by the
Purchasers. From and after the Closing Date, subject to any applicable limitations set forth in Section 6.1 and Section 6.2, each Purchaser, severally and not jointly and severally, shall indemnify and hold the Company
and its affiliates, and their respective officers, directors, stockholders, partners, managers, members, employees, agents, and representatives (the “Company Indemnified Parties”) harmless from and against all Losses arising out of
or relating to any breach or violation of the representations, warranties, covenants or agreements of such Purchaser set forth in this Agreement or in any other certificate or document delivered by such Purchaser pursuant to this Agreement (in each
case disregarding for this purpose any materiality or similar qualifiers contained herein or therein). 
 6.5
Procedure for Indemnification. Any party making a claim for indemnification hereunder shall promptly notify the indemnifying party of the claim in writing, describing the claim in reasonable detail, the amount
thereof, and the basis therefor; provided, however, that the failure to provide prompt notice shall not relieve the indemnifying party of its indemnification obligations hereunder, except to the extent that the indemnifying party is actually
prejudiced by the failure to give such prompt notice. The party from whom indemnification is sought shall respond to each such claim within thirty (30) days of receipt of such notice. No action shall be taken pursuant to the provisions of this
Agreement or otherwise by the party seeking indemnification until the later of (i) the expiration of the 30-day response period (unless reasonably necessary to protect the rights of the party seeking indemnification), or (ii) 30 days
following the termination of the 30-day response period if a response, received within such 30 day period by the party seeking indemnification, requests an opportunity to cure the matter giving rise to indemnification (and, in such event, the amount
of such claim for indemnification shall be reduced to the extent so cured). 

  
 -16- 

Table of Contents

 6.6 Remedies Exclusive. Subject to Section 4.2
hereof and except with respect to the assertion of any claim based on fraud, the remedies provided in this Article VI shall be the exclusive remedies of the parties hereto after the Closing in connection with the transactions contemplated by
this Agreement, including without limitation any breach or non-performance of any representation, warranty, covenant or agreement contained herein or in any other certificate or document delivered pursuant to this Agreement. Subject to
Section 4.2 hereof and except with respect to the assertion of any claim based on fraud, after the Closing, no party may commence any suit, action or proceeding against any other party hereto with respect to the subject matter of this
Agreement, whether in contract, tort or otherwise, except to enforce such party’s express rights under this Article VI. No officer, director, employee or agent of the Company shall be personally liable in any manner or to any extent
(whether in contract or tort) under or in connection with this Agreement. The limitation of liability provided in this Section 6.6 is in addition to, and not in limitation of, any limitation on liability applicable to any such person
provided by law or by this Agreement or any other contract, agreement or instrument. 
 6.7 Right of
Set-Off. If the indemnifying party has not satisfied in cash any indemnification obligation owed by them hereunder, the party seeking indemnification may, at its discretion, satisfy the unpaid portion of such obligation by, to the extent
permitted by law, setting-off against any amounts due and owing from the party seeking indemnification to the indemnifying party. 
 
ARTICLE VII 
 MISCELLANEOUS 

7.1 Broker’s Fee. Each of the parties hereto hereby represents to the other that, on the basis of
any actions and agreements by it, there are no brokers or finders entitled to compensation in connection with the sale of the Shares to the Purchasers. 

7.2 Assignment. This Agreement and the rights and obligations hereunder shall not be assigned, delegated,
or otherwise transferred (whether by operation of law, by contract, or otherwise) without the prior written consent of the other party hereto; provided, however, that each Purchaser may, without obtaining the prior written consent of the Company,
assign, delegate, or otherwise transfer its rights and obligations hereunder to any Affiliate of such Purchaser who is an “accredited investor” as set forth in Section 3.1 and agrees to be bound by the terms and conditions of
this Agreement. The Company shall execute such acknowledgements of such assignments and collateral assignments in such forms as a Purchaser may from time to time reasonably request. Any attempted assignment, delegation, or transfer in violation of
this Section 7.2 shall be void and of no force or effect. “Affiliate” means, in respect of any Person, any other Person that is directly or indirectly controlling, controlled by, or under common control with such Person
or any of its Subsidiaries, and the term “control” (including the terms “controlled by” and “under common control with”) means having, directly or indirectly, the power to direct or cause the direction of the management
and policies of a Person, whether through ownership of voting securities or by contract or otherwise. 
 7.3
Expenses. (a) The legal, accounting, financing, due diligence and other costs and expenses incurred by the Purchasers in connection with the transactions contemplated hereby will be borne by the Purchasers
and (b) the legal and other costs and expenses incurred by the Company in connection with the transactions contemplated hereby will be borne by the Company. 

  
 -17- 

Table of Contents

 7.4 Notices. All notices, requests, consents and other
communications hereunder shall be in writing, shall be mailed by first-class registered or certified airmail, facsimile (with receipt confirmed by telephone) or nationally recognized overnight express courier postage prepaid, and shall be deemed
given when so mailed and shall be delivered as addressed as follows: 
  

	 	(a)	if to the Company, to: 

 Revolution Lighting Technologies, Inc. 

177 Broad Street, 12th Floor 

Stamford, CT 06901 

Facsimile:       (704) 405-0422 

Attention:        Chief Executive Officer 

with copies to: 
 Lowenstein
Sandler LLP 
 1251 Avenue of the America 

New York, NY 10020 

Facsimile:       (973) 535-3357 

Attention:        Marita A. Makinen, Esq. 

or to such other person at such other place as the Company shall designate to the Purchasers in writing; and 

 

	 	(b)	if to the Purchasers, to: 

 c/o American Money Management Corp. 

301 East Fourth Street 

Cincinnati, Ohio 45202 

Facsimile:       (513) 579-2911 

Attention:        Joseph A. Haverkamp 

with a copy to: 
 c/o American
Financial Group, Inc. 
 27th Floor 

301 East Fourth Street 

Cincinnati, Ohio 45202 

Facsimile:       (513) 352-9272 

Attention:        Mark A. Weiss 

or at such other address as may have been furnished to the Company in writing. 

7.5 Changes. This Agreement may not be modified or amended except pursuant to an instrument in writing
signed by the Company and the Purchasers. 

  
 -18- 

Table of Contents

 7.6 Headings. The headings of the various Sections of this
Agreement have been inserted for convenience of reference only and shall not be deemed to be part of this Agreement. 
 7.7 
Severability. In case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be
affected or impaired thereby. 
 7.8 Governing Law. This Agreement shall be governed by and construed
in accordance with the laws of the State of New York, without giving effect to the principles of conflicts of laws. 
 7.9 
Counterparts. This Agreement may be executed in two or more counterparts, each of which shall constitute an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more
counterparts have been signed by each party hereto and delivered to the other parties. The submission of a signature page transmitted by facsimile (or other electronic transmission, including PDF) shall be considered as an “original”
signature page for purposes of this Agreement. 
 7.10 Entire Agreement. This Agreement, the Schedules
and the other agreements, documents and instruments contemplated hereby and referenced herein contain the entire understanding of the parties, and there are no further or other agreements or understanding, written or oral, in effect between the
parties relating to the subject matter hereof. 
 7.11 No Third-Party Beneficiaries. This Agreement is
intended for the benefit of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other person (other than the Purchaser Indemnified Parties and the
Company Indemnified Parties). 
 [Signatures appear on following page.] 

  
 -19- 

Table of Contents

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed by their duly
authorized representatives as of the day and year first above written. 
  

					
	COMPANY:
	
	REVOLUTION LIGHTING TECHNOLOGIES, INC.
		
	By	 	 /s/ James A. DePalma

		 	Name:	 	James A. DePalma
		 	Title:	 	Chief Financial Officer
		
	PURCHASERS:	 	
	
	GREAT AMERICAN LIFE INSURANCE COMPANY
		
	By	 	 /s/ Mark F. Muething

		 	Name:	 	Mark F. Muething
		 	Title:	 	Executive Vice President
	
	GREAT AMERICAN INSURANCE COMPANY
		
	By	 	 /s/ Stephen C. Beraha

		 	Name:	 	Stephen C. Beraha
		 	Title:	 	Assistant Vice President
	
	BFLT, LLC
		
	By	 	 /s/ John B. Berding

		 	Name:	 	John B. Berding
		 	Title:	 	Manager

 [Signature Page to Investment Agreement]Registration Rights Agreement

 Exhibit 10.3 

REGISTRATION RIGHTS AGREEMENT 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 5, 2015, by and among
Revolution Lighting Technologies, Inc. (the “Company”), a corporation organized under the laws of the State of Delaware, with its principal offices at 177 Broad Street, 12th
Floor, Stamford, CT 06901, Great American Insurance Company, a corporation organized under the laws of the State of Ohio, with its principal offices at 301 East Fourth Street, Cincinnati, OH 45202 (“Great American”), Great American
Life Insurance Company, a corporation organized under the laws of the State of Ohio, with its principal offices at 301 East Fourth Street, Cincinnati, OH 45202 (“Great American Life”), and BFLT, LLC, an Ohio limited liability
company (“BFLT”, and together with Great American and Great American Life, the “Purchasers”). This Agreement is being entered into pursuant to the Investment Agreement dated as of the date hereof between the Company
and the Purchasers (the “Investment Agreement”). 
 The Company and the Purchaser hereby agree as follows: 

1. Definitions. 

Capitalized terms used and not otherwise defined herein shall have the meanings given such terms in the Investment Agreement. As used in this
Agreement, the following terms shall have the following meanings: 
 “Affiliate” shall mean, in respect of any Person, any
other Person that is directly or indirectly controlling, controlled by, or under common control with such Person, and the term “control” (including the terms “controlled by” and “under common control with”) means
having, directly or indirectly, the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities or by contract or otherwise. 

“Board” or “Board of Directors” shall mean the board of directors of the Company. 

“Business Day” shall mean any day other than a Saturday, Sunday or a day on which the banks in New York, New York are
authorized by law or executive order to be closed. 
 “Closing Date” shall mean the date of the closing of the
purchase and sale of the Shares pursuant to the Investment Agreement. 
 “SEC” shall mean the Securities and
Exchange Commission. 
 “Common Stock” shall mean the Company’s common stock, par value $0.001 per share. 

“Company Indemnitees” shall have the meaning set forth in Section 5(b). 

“Effective Date” shall mean, with respect to the Registration Statement, the earlier of the date which is five
(5) Business Days after the date on which the Commission informs the Company (i) that the Commission will not review the Registration Statement or (ii) that the Company is permitted by the SEC to accelerate the effectiveness of the
Registration Statement. 

 “Effective Period” shall mean the earlier of (x) one year from the
Effective Date, (y) the date when all Registrable Securities covered by such Registration Statement have been sold, or (z) the date on which the Registrable Securities may be sold without any restriction pursuant to Rule 144 as determined
by the counsel to the Company pursuant to a written opinion letter addressed to the Company’s transfer agent to such effect 

“Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, together with the rules and regulations
promulgated thereunder. 
 “Excluded Registration” shall mean (i) a registration relating to the sale of
securities to employees of the Company or a subsidiary thereof pursuant to a stock option, stock purchase, or similar plan; (ii) a registration on Form S-4 or otherwise relating to a transaction covered by Rule 145 promulgated by the SEC
pursuant to the Securities Act; or (iii) a registration on Form S-8 or any similar successor form thereto. 

“Holder” or “Holders” shall mean the holder or holders, as the case may be, from time to time of Registrable
Securities. 
 “Holder Indemnitees” shall have the meaning set forth in Section 5(a). 

“Incidental Registration” shall have the meaning set forth in Section 2(a). 

“Indemnitees” shall have the meaning set forth in Section 5(c). 

“Person” shall mean an individual or a corporation, partnership, trust, incorporated or unincorporated association, joint
venture, limited liability company, joint stock company, government (or an agency or political subdivision thereof) or other entity of any kind. 

“Proceeding” shall mean an action, claim, suit, investigation or proceeding (including, without limitation, an investigation
or partial proceeding, such as a deposition), whether commenced or threatened. 
 “Prospectus” shall mean the
prospectus included in the Registration Statement (including, without limitation, a prospectus that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A
promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering of any portion of the Registrable Securities covered by the Registration Statement, and all other amendments
and supplements to such prospectus, including post-effective amendments, and all material incorporated by reference in such prospectus. 

“Registrable Securities” shall mean the Shares, provided, however, that such securities shall no longer be deemed
Registrable Securities if (x) such shares have been resold or otherwise transferred pursuant to a Registration Statement that has been declared effective by the SEC; (y) such shares are sold in compliance with Rule 144, or (z) such
shares have ceased to be outstanding (whether as a result of redemption, repurchase, cancellation or otherwise). 

“Registration Request” shall have the meaning set forth in Section 2(a). 

  
 -2- 

 “Registration Statement” shall mean any registration statement contemplated by
Section 2, including (in each case) the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material incorporated by reference
in such registration statement. 
 “Rule 144” shall mean Rule 144 promulgated by the SEC pursuant to the Securities
Act, as such rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the SEC having substantially the same effect as such rule. 

“Securities Act” shall mean the Securities Act of 1933, as amended, together with the rules and regulations promulgated
thereunder. 
 “Selling Expenses” shall mean all underwriting discounts, selling commissions, and stock transfer
taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in Section 4.

 “Selling Holder Counsel” shall have the meaning set forth in Section 4. 

“Term”shall mean the period from the Closing Date until the earlier of (i) the date on which all Registrable Securities
cease to be Registrable Securities, and (ii) the date on which all Registrable Securities may be sold without restriction pursuant to Rule 144. 

“Violation” shall have the meaning set forth in Section 5(a). 

2. Piggy-Back Registration Rights. 

(a) If at any time during the Term, the Company shall determine to prepare and file with the SEC a registration statement (an
“Incidental Registration”) relating to an offering for its own account or the account of others under the Securities Act of any of its Common Stock, other than an Excluded Registration, then the Company shall send to each Holder
written notice of such determination and if, within fifteen (15) days after receipt of such notice, any such Holder shall so request in writing (the “Registration Request”), the Company shall include in the Incidental
Registration all or any part of such Registrable Securities such Holder requests to be registered. 
 (b) Notwithstanding
Section 2(a): 
 (i) the Company shall not be obligated pursuant to this Section 2 to effect a registration of
Registrable Securities requested pursuant to a timely Registration Request if the Company discontinues, terminates or withdraws the related Incidental Registration at any time prior to the effective date of any Registration Statement filed in
connection therewith. The expenses of such withdrawn registration shall be borne by the Company in accordance with Section 4; and 

(ii) if the Incidental Registration is, in whole or in part, an underwritten public offering, and the managing underwriter of the Incidental
Registration advises the Company that the inclusion of all Registrable Securities proposed to be included in the underwritten public 

  
 -3- 

 
offering, together with any other issued and outstanding shares of the Company’s common stock proposed to be included therein (such other shares hereinafter collectively referred to as
the “Other Shares”), would interfere with the successful marketing of the Company’s securities, then the Company will include in the Incidental Registration to the extent of the number which the Company is so advised can be
sold in such offering, 
 (1) if such Incidental Registration is a result of a demand by RVL 1 LLC to register securities held by
it, first, the securities RVL 1 LLC has requested to be registered and second, the Registrable Securities of the Holder requesting to be included in the Incidental Registration and all other securities requested to be included in such
Registration on a pro rata basis; or 
 (2) if such Incidental Registration is not a result of a demand by RVL 1 LLC to register securities
held by it, first, the securities the Company proposes to sell for its own account in the Incidental Registration and second, the Registrable Securities of the Holder requesting to be included in the Incidental Registration and all
other securities requested to be included in such Registration, pro rata based on the total number of securities each Person is entitled to request to be included in such Registration. 

3. Registration Procedures. If and whenever the Company is required pursuant to Section 2 to effect a registration of
Registrable Securities, subject to the provisions of Section 2: 
 (a) The Company shall prepare and file with the SEC a
Registration Statement covering such Registrable Securities and use commercially reasonable efforts to cause such Registration Statement to become effective and to keep such Registration Statement continuously effective under the Securities Act not
exceeding the Effective Period. 
 (b) The Company shall prepare and file with the SEC such amendments, including post-effective amendments,
to the Registration Statement as may be necessary to keep the Registration Statement continuously effective as to the applicable Registrable Securities for the Effective Period and prepare and file with the SEC such additional Registration
Statements, if necessary, in order to register for resale under the Securities Act all of the Registrable Securities; and shall (i) cause the related Prospectus to be amended or supplemented by any required Prospectus supplement, and as so
supplemented or amended to be filed pursuant to Rule 424 (or any similar provisions then in force) promulgated under the Securities Act; (ii) respond promptly to any comments received from the SEC with respect to the Registration Statement or
any amendment thereto and promptly provide the Holders true and complete copies of all correspondence from and to the SEC relating to the Registration Statement; and (iii) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by the Registration Statement during the applicable period in accordance with the intended methods of disposition by the Holders thereof set forth in the
Registration Statement as so amended or in such Prospectus as so supplemented. 
 (c) The Company shall promptly notify the Holders of
Registrable Securities (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to the Registration Statement is filed; (B) when the SEC notifies the Company whether there will be a “review” of such
Registration Statement and whenever the SEC comments in writing on such 

  
 -4- 

 
Registration Statement and (C) with respect to the Registration Statement or any post-effective amendment, when the same has become effective; (ii) of any request by the SEC or any
other Federal or state governmental authority for amendments or supplements to the Registration Statement or Prospectus or for additional information; (iii) of the issuance by the SEC of any stop order suspending the effectiveness of the
Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification with respect to the suspension of the qualification or
exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the occurrence of any event of which the Company becomes aware that
makes any statement made in the Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires any revisions to the Registration Statement,
Prospectus or other documents so that, in the case of the Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. 
 (d) The Company
shall use its reasonable best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of, (i) any order suspending the effectiveness of the Registration Statement or (ii) any suspension of the qualification (or exemption
from qualification) of any of the Registrable Securities for sale in any United States jurisdiction, at the earliest practicable moment. 

(e) If requested by the Holders of a majority of the Registrable Securities, the Company shall (i) promptly incorporate in a Prospectus
supplement or post-effective amendment to the Registration Statement such information as the Company reasonably agrees should be included therein and (ii) make all required filings of such Prospectus supplement or such post-effective amendment
as soon as reasonably practicable after the Company has received notification of the matters to be incorporated in such Prospectus supplement or post-effective amendment. 

(f) The Company shall furnish to each Holder, without charge and upon request, at least one conformed copy of each Registration Statement and
each amendment thereto, including financial statements and schedules, and, to the extent requested by such Person, all documents incorporated or deemed to be incorporated therein by reference, and all exhibits (including those previously furnished
or incorporated by reference) promptly after the filing of such documents with the SEC. 
 (g) The Company shall promptly deliver to each
Holder, without charge, as many copies of the Prospectus or Prospectuses (including each form of prospectus) and each amendment or supplement thereto as such Persons may reasonably request; and the Company hereby consents to the use of such
Prospectus and each amendment or supplement thereto by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or supplement thereto. 

(h) Prior to any public offering of Registrable Securities, the Company shall use its reasonable best efforts to register or qualify or
cooperate with the selling Holders in connection 

  
 -5- 

 
with the registration or qualification (or exemption from such registration or qualification) of such Registrable Securities for offer and sale under the securities or blue sky laws of such
jurisdictions within the United States as any Holder reasonably requests in writing, to keep each such registration or qualification (or exemption therefrom) effective during the Effective Period and to do any and all other acts or things necessary
or advisable to enable the disposition in such jurisdictions of the Registrable Securities covered by a Registration Statement; provided, however, the Company shall in no event be required to (x) qualify to do business in any state where
it is not then qualified or (y) take any action that would subject it to tax or to the general service of process in any such state where it is not then subject. 

(i) The Company shall, in the case of an underwritten offering, furnish, at the request of any Holder requesting registration of Registrable
Securities pursuant to Section 2, on the date that such shares of Registrable Securities are delivered to the underwriters for sale pursuant to such registration (1) an opinion, dated such date, of the independent counsel
representing the Company for the purposes of such registration, addressed to the underwriters, in customary form and covering matters of the type customarily covered in such legal opinions; and (2) a comfort letter dated such date, from the
independent certified public accountants of the Company, addressed to the underwriters, in a customary form and covering matters of the type customarily covered by such comfort letters and as the underwriters shall reasonably request. 

(j) The Company shall enter into customary agreements (including an underwriting agreement in customary form) and take such other actions as
are reasonably required in order to expedite or facilitate the disposition of such Registrable Securities. 
 (k) The Company shall
cooperate with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold pursuant to a Registration Statement, and to enable such Registrable Securities to be in such denominations
and registered in such names as any Holder may reasonably request. 
 (l) Upon the occurrence of any event contemplated by
Section 3(c)(v), the Company shall promptly prepare a supplement or amendment, including a post-effective amendment, to the Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be
incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither the Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. 

(m) The Company shall use its reasonable best efforts to cause all Registrable Securities relating to the Registration Statement to be listed
on the NASDAQ Stock Market or any other securities exchange, quotation system or market, if any, on which similar securities issued by the Company are then listed or traded as and when required pursuant to the Investment Agreement. 

(n) The Company may require each selling Holder to furnish to the Company information regarding such Holder and the distribution of such
Registrable Securities as is required by law to be disclosed in the Registration Statement, and the Company may exclude 

  
 -6- 

 
from such registration the Registrable Securities of any such Holder who fails to furnish such information within fifteen (15) days after receiving a written request from the Company for
such information. 
 (o) Each Holder covenants and agrees that (i) it will not sell any Registrable Securities under the Registration
Statement until it has received copies of the Prospectus as then amended or supplemented as contemplated in Section 3(g) and notice from the Company that such Registration Statement and any post-effective amendments thereto have become
effective as contemplated by Section 3(c) and (ii) it and its officers, directors or Affiliates, if any, will comply with the prospectus delivery requirements of the Securities Act as applicable to them in connection with sales of
Registrable Securities pursuant to the Registration Statement. 
 (p) Each Holder agrees by its acquisition of such Registrable Securities
that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(c)(ii), 3(c)(iii), 3(c)(iv), 3(c)(v) or 3(q), such Holder will forthwith discontinue
disposition of such Registrable Securities under the Registration Statement until such Holder’s receipt of the copies of the supplemented Prospectus and/or amended Registration Statement contemplated by Section 3(l), or until it is
advised in writing by the Company that the use of the applicable Prospectus may be resumed, and, in either case, has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated by reference in such
Prospectus or Registration Statement. 
 (q) If (i) there is material non-public information regarding the Company which the Board
reasonably and in good faith determines not to be in the Company’s best interest to disclose and which the Company is not otherwise required to disclose, or (ii) there is a significant business opportunity (including, but not limited to,
the acquisition or disposition of assets (other than in the ordinary course of business) or any merger, consolidation, tender offer or other similar transaction) available to the Company which the Board reasonably determines not to be in the
Company’s best interest to disclose, then the Company may postpone or suspend filing or effectiveness of a Registration Statement for a period not to exceed ninety (90) consecutive days, provided that the Company may not postpone or
suspend its obligation under this Section 3(q) for more than one hundred and twenty (120) days in the aggregate during any twelve month period. 

4. Registration Expenses. All reasonable fees and expenses incident to the performance of or compliance with this Agreement by the
Company (excluding underwriters’ discounts and commissions), except as and to the extent specified in this Section 4, shall be borne by the Company whether or not the Registration Statement is filed or becomes effective and whether
or not any Registrable Securities are sold pursuant to the Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without
limitation, fees and expenses (A) with respect to filings required to be made with the NASDAQ Stock Market and each other securities exchange or market on which Registrable Securities are required hereunder to be listed, (B) with respect
to filings required to be made with the Financial Industry Regulatory Authority, Inc. and (C) in compliance with state securities or blue sky laws), (ii) printing expenses (including, without limitation, expenses of printing certificates
for Registrable Securities and of printing prospectuses if the printing of prospectuses is requested by the holders of a majority of the 

  
 -7- 

 
Registrable Securities included in the Registration Statement), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company,
(v) reasonable fees and disbursements of one counsel for the selling Holders (“Selling Holder Counsel”), (vi) Securities Act liability insurance, if the Company so desires such insurance, and (vii) fees and expenses
of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement, including, without limitation, the Company’s independent public accountants. In addition, the Company shall be
responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or
accounting duties), the expense of any annual audit, the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange as required hereunder. All Selling Expenses relating to Registrable
Securities registered pursuant to Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable Securities registered on their behalf. 

5. Indemnification. 
 (a)
The Company shall indemnify and hold harmless each selling Holder, the officers, directors, partners, agents and employees of each selling Holder, any underwriter (as defined in the Securities Act) for such Holder and each Person, if any, who
controls such selling Holder or underwriter within the meaning of the Securities Act or the Exchange Act and their respective agents (collectively, the “Holder Indemnitees”), against any losses, claims, damages or liabilities (joint
or several) to which they or any of them may become subject under the Securities Act, the Exchange Act or any other federal or state law, rule or regulation, including any amount paid in settlement of any litigation, commenced or threatened, and to
reimburse them for any reasonable legal or other expenses incurred by them in connection therewith, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon (A) any untrue statement
or alleged untrue statement of a material fact contained in the Registration Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto; (B) any omission or alleged omission to
state therein a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading; or (C) any violation or alleged violation by the Company of the
Securities Act, the Exchange Act, any state securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law in connection with any matter relating to the Registration Statement (each, a
“Violation”); provided, however, the indemnity agreement contained in this Section 5(a) shall not (i) apply to any loss, claim, damage, liability or action arising out of, or based upon, a Violation
which occurs in reliance upon and in conformity with written information furnished by any Holder expressly for use in connection with such registration; or (ii) in the case of a sale directly by a Holder (including a sale of such Registrable
Securities through any underwriter retained by such Holder engaging in a distribution solely on behalf of such Holder), inure to the benefit of any Holder Indemnitee to the extent that any such loss, claim, damage, liability or action results from
or is based upon an untrue statement or alleged untrue statement or omission or alleged omission that was contained in a preliminary prospectus and corrected in a final or amended prospectus, and such Holder, having previously been provided with
copies of such final or amended prospectus by the Company, failed to deliver a copy of the final or amended prospectus at or prior to the confirmation of the sale of the Registrable Securities to the Person asserting any such loss, claim, damage or
liability in any case in which such delivery is required by the Securities Act. 

  
 -8- 

 (b) Each Holder shall indemnify and hold harmless the Company, each of its directors, each of its
officers who has signed the Registration Statement, each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange Act, each agent and any underwriter for the Company, and any other selling Holder or other
stockholder selling securities in such Registration Statement or any of its directors, officers, partners, agents or employees or any Person who controls such selling Holder or such other stockholder or such underwriter (collectively, the
“Company Indemnitees”) against any losses, claims, damages or liabilities (joint or several) to which any Company Indemnitee may become subject under the Securities Act, the Exchange Act or other federal or state law or regulation,
including any amount paid in settlement of any litigation, commenced or threatened, and to reimburse them for any reasonable legal or other expenses incurred by them in connection therewith, insofar as such losses, claims, damages or liabilities (or
actions in respect thereto) arise out of or are based upon any Violation, in each case to the extent (and only to the extent) that (i) such Violation occurs in reliance upon and in conformity with written information furnished by or on behalf
of such selling Holder expressly for use in connection with such registration and (ii) is limited to an amount not exceeding the net proceeds received by such Holder with respect to securities sold pursuant to such Registration Statement;
provided, however, that the indemnity agreement contained in this Section 5(b) shall not, in the case of a sale directly by the Company of its securities (including a sale of such securities through any underwriter retained
by the Company to engage in a distribution solely on behalf of the Company), inure to the benefit of any Person to the extent that any such loss, claim, damage, liability or action results from an untrue statement or alleged untrue statement or
omission or alleged omission that was contained in a preliminary prospectus and corrected in a final or amended prospectus, and the Company failed to deliver a copy of the final or amended prospectus at or prior to the confirmation of the sale of
the securities to the Person asserting any such loss, claim, damage or liability in any case in which such delivery is required by the Securities Act. 

(c) Promptly after receipt by any Company Indemnitee or Holder Indemnitee (collectively, the “Indemnitees”) under this
Section 5 of notice of the commencement of any action (including any governmental action), such Indemnitee will, if a claim in respect thereof is to be made against any indemnifying party under this Section 5, deliver to the
indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to
assume and control the defense thereof with counsel mutually satisfactory to the parties; provided, however, that such Indemnitee shall have the right to retain its own counsel, with the fees and expenses to be paid by the indemnifying
party, if representation of such Indemnitee by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests, as reasonably determined by either party, between such Indemnitee and any other
party represented by such counsel in such proceeding. In no event shall the Indemnitees be entitled to more than one firm of counsel at the expense of the indemnifying party. The failure to deliver written notice to the indemnifying party within a
reasonable time of the commencement of any such action, if materially prejudicial to its ability to defend such action, shall relieve such indemnifying party of any liability to the Indemnitee under this Section 5 to the extent of such
prejudice, but the omission to so deliver 

  
 -9- 

 
written notice to the indemnifying party will not relieve it of any liability that it may have to such Indemnitee otherwise than under this Section 5. If the indemnifying party
advises an Indemnitee that it will contest a claim for indemnification hereunder, or fails, within thirty (30) days of receipt of any indemnification notice to notify, in writing, such Indemnitee of its election to defend, settle or compromise,
at its sole cost and expense, any action, proceeding or claim (or discontinues its defense at any time after it commences such defense), then the Indemnitee may, at its option, defend, settle or otherwise compromise or pay such action or claim in
each case at the indemnifying party’s expense. In any event, unless and until the indemnifying party elects in writing to assume and does so assume the defense of any such claim, proceeding or action, the Indemnitee’s reasonable costs and
expenses arising out of the defense, settlement or compromise of any such action, claim or proceeding shall be losses subject to indemnification hereunder. The Indemnitee shall cooperate fully with the indemnifying party in connection with any
negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available to the Indemnitee that relates to such action or claim. The indemnifying party shall keep
the Indemnitee fully informed at all times as to the status of the defense or any settlement negotiations with respect thereto. If the indemnifying party elects not to defend any such action or claim, the Indemnitee party shall keep the indemnifying
party informed at all times as to the status of the defense; provided, however, that the failure to keep the indemnifying party so informed shall not affect the obligations of the indemnifying party hereunder. No indemnifying party shall be
liable for any settlement of any action, claim or proceeding effected without its written consent; provided, however, that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall,
without the written consent of the Indemnitee, consent to entry of any judgment or enter into any settlement that (i) does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnitee of a general
written release from all liability with respect to such claim or litigation or (ii) contains an admission of guilt on the part of the Indemnitee. 

(d) The obligations of the Company and the Holders under this Section 5 shall survive the completion of any offering of
Registrable Securities in a Registration Statement whether under Section 2 or otherwise. 
 (e) If the indemnification provided
for in this Section 5 is unavailable to a party that would have been an Indemnitee under this Section 5 in respect of any losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred to
herein, then each party that would have been an indemnifying party hereunder shall, in lieu of indemnifying such Indemnitee, contribute to the amount paid or payable by such Indemnitee as a result of such losses, claims, damages or liabilities (or
actions or proceedings in respect thereof) in such proportion as is appropriate to reflect the relative fault of such indemnifying party, on the one hand, and such Indemnitee, on the other hand, in connection with the statements or omissions which
resulted in such losses, claims, damages or liabilities (or actions or proceedings in respect thereof). The relative fault shall be determined by reference to, among other things, whether the Violation relates to information supplied by such
indemnifying party or such Indemnitee and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such Violation. The parties agree that it would not be just and equitable if contribution pursuant to
this Section 5(e) were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the preceding sentence.

  
 -10- 

 
The amount paid or payable by a contributing party as a result of the losses, claims, damages or liabilities (or actions or proceedings in respect thereof) referred to above in this
Section 5(e) shall include any legal or other expenses reasonably incurred by such Indemnitee in connection with investigating or defending any such action or claim. No Person guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 

(f) The indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of an
Indemnitee against an indemnifying party or others and (ii) any liabilities the indemnifying party may be subject to pursuant to applicable law. 

6. Rule 144 and Rule 144A. With a view to making available to the Holders the benefits of Rule 144, Rule 144A and any other rule or
regulation of the SEC that may at any time permit a Holder to sell securities of the Company without registration, the Company shall: 
 (a)
file with the SEC in a timely manner all reports and other documents required of the Company under the Exchange Act and the rules and regulations promulgated thereunder; 

(b) if not required to file such reports and documents referred to in subsection (a) above, keep publicly available certain information
regarding the Company, as contemplated by Rule 144(c) of the Securities Act; 
 (c) take all other actions reasonably necessary to enable a
Holder to sell the Registrable Securities without registration under the Securities Act within the limitation of the exemptions provided by Rule 144 and Rule 144A; and 

(d) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request (i) to the extent accurate, a
written statement by the Company that it has complied with the reporting requirements of SEC Rule 144, the Securities Act, and the Exchange Act, or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3, and (ii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration or pursuant
to Form S-3. 
 7. Miscellaneous. 

(a) Remedies. In the event of a breach by the Company or by a Holder, of any of their obligations under this Agreement, each Holder or
the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. The Company
and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for
specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate. 
 (b) Entire
Agreement; Amendment. This Agreement and the Investment Agreement contain the entire understanding and agreement of the parties with respect to the matters covered 

  
 -11- 

 
hereby and, except as specifically set forth herein or in the Investment Agreement, neither the Company nor the Purchaser makes any representation, warranty, covenant or undertaking with respect
to such matters, and they supersede all prior understandings and agreements with respect to said subject matter, all of which are merged herein. No provision of this Agreement may be waived or amended other than by a written instrument signed by the
Company and the Holders of at least a majority of all Registrable Securities then outstanding; provided that any waiver or amendment that adversely affects a Holder without adversely affecting other Holders in a similar manner must be approved in
writing by such Holder. Any amendment or waiver effected in accordance with this Section 7(b) shall be binding upon each Holder (and their permitted assigns) and the Company. 

(c) Notices. All notices, requests, consents and other communications hereunder shall be in writing, shall be mailed by first-class
registered or certified airmail, facsimile (with receipt confirmed by telephone) or nationally recognized overnight express courier postage prepaid, and shall be deemed given when so mailed and shall be delivered as addressed as follows: 

If to the Company, to: 

Revolution Lighting Technologies, Inc. 

177 Broad Street, 12th Floor 

Stamford, CT 06901 
 Facsimile:
(704) 405-0422 
 Attention: Chief Executive Officer 

with copies to: 
 Lowenstein
Sandler LLP 
 1251 Avenue of the America, 17th Floor 

New York, NY 10020 
 Facsimile:
(973) 535-3357 
 Attention: Marita A. Makinen, Esq. 

or to such other person at such other place as the Company shall designate to the Purchasers in writing. 

If to the Purchasers: 
 c/o
American Money Management Corp. 
 301 East Fourth Street 

Cincinnati, Ohio 45202 

Facsimile: (513) 579-2911 

Attention: Joseph A. Haverkamp 

with a copy to: 
 c/o American
Financial Group, Inc. 

  
 -12- 

 27th Floor 

301 East Fourth Street 

Cincinnati, Ohio 45202 

Facsimile: (513) 352-9272 

Attention: Mark A. Weiss 
 or at
such other address as may have been furnished to the Company in writing. 
 Any party hereto may from time to time change its address for notices by giving
written notice of such changed address to the other party hereto. 
 (d) Waivers. No waiver by either party of any default with
respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to
exercise any right hereunder in any manner impair the exercise of any such right accruing to it thereafter. 
 (e) Successors and
Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns and shall inure to the benefit of each Holder and its successors and assigns. The Company may not assign this
Agreement or any of its rights or obligations hereunder without the prior written consent of each Holder. The Purchaser may assign its rights hereunder in the manner and to the Persons as permitted herein and under the Investment Agreement. 

(f) Assignment of Registration Rights. The rights of each Holder hereunder, including the right to have the Company register for resale
Registrable Securities in accordance with the terms of this Agreement, shall be assignable by each Holder of all or a portion of the Registrable Securities if: (i) the Holder agrees in writing with the transferee or assignee to assign such
rights, and a copy of such agreement is furnished to the Company within a reasonable time after such assignment, (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of (a) the name
and address of such transferee or assignee, and (b) the securities with respect to which such registration rights are being transferred or assigned, (iii) following such transfer or assignment the further disposition of such securities by
the transferee or assignee is restricted under the Securities Act and applicable state securities laws, (iv) at or before the time the Company receives the written notice contemplated by clause (ii) of this Section, the transferee or
assignee agrees in writing with the Company to be bound by all of the provisions of this Agreement, and (v) such transfer shall have been made in accordance with the applicable requirements of the Investment Agreement. The rights to assignment
shall apply to the Holders (and to subsequent) successors and assigns. 
 (g) Counterparts. This Agreement may be executed in any
number of counterparts, each of which when so executed shall be deemed to be an original and, all of which taken together shall constitute one and the same Agreement. In the event that any signature is delivered by facsimile transmission, such
signature shall create a valid binding obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if such facsimile signature were the original thereof. 

  
 -13- 

 (h) Termination. This Agreement shall terminate on the earlier of (i) the date on
which all remaining Registrable Securities may be sold without restriction pursuant to Rule 144 of the Securities Act, or (ii) the date when all Registrable Securities have been sold. 

(i) Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware (with respect
to matters of corporation law) and the laws of the State of New York (with respect to all other matters), without regard to principles of conflicts of law thereof. 

(j) Severability. The provisions of this Agreement are severable and, in the event that any court of competent jurisdiction shall
determine that any one or more of the provisions or part of the provisions contained in this Agreement shall, for any reason, be held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not
affect any other provision or part of a provision of this Agreement and this Agreement shall be reformed and construed as if such invalid or illegal or unenforceable provision, or part of such provision, had never been contained herein, so that such
provisions would be valid, legal and enforceable to the maximum extent possible. 
 (k) Headings. The headings herein are for
convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. 
 (l)
Submission to Jurisdiction; Waiver of Jury Trial. Each of the parties (a) submits to the jurisdiction of any state or federal court sitting in the State of New York in any action or proceeding arising out of or relating to this
Agreement, (b) agrees that all claims in respect of such action or proceeding may be heard and determined in any such court, and (c) agrees not to bring any action or proceeding arising out of or relating to this Agreement in any other
court. Each of the parties waives any defense of inconvenient forum to the maintenance of any action or proceeding so brought and waives any bond, surety or other security that might be required of any other party with respect thereto. Any party may
make service on another party by sending or delivering a copy of the process to the party to be served at the address and in the manner provided for the giving of notices in Section 7(c). Nothing in this Section 7(l),
however, shall affect the right of any party to serve legal process in any other manner permitted by law. IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THE TRANSACTIONS CONTEMPLATED HEREBY, THE PARTIES HERETO IRREVOCABLY CONSENT TO TRIAL
WITHOUT A JURY. 
 [Remainder of page intentionally left blank] 

  
 -14- 

 IN WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly
executed by their respective authorized officers as of the date first above written. 
  

			
	COMPANY:
	
	REVOLUTION LIGHTING TECHNOLOGIES, INC.
		
	By:	 	 /s/ James A. DePalma

		 	Name:  James A. DePalma
		 	Title:    Chief Financial Officer
	
	PURCHASERS:
	
	GREAT AMERICAN LIFE INSURANCE COMPANY
		
	By	 	 /s/ Mark F. Muething

		 	Name:  Mark F. Muething
		 	Title:    Executive Vice President
	
	GREAT AMERICAN INSURANCE COMPANY
		
	By	 	 /s/ Stephen C. Beraha

		 	Name:  Stephen C. Beraha
		 	Title:    Assistant Vice President
	
	BFLT, LLC
		
	By	 	 /s/ John B. Berding

		 	Name:  John B. Berding
		 	Title:    Manager

 [Signature Page to Registration Rights Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00248-of-00352.parquet"}]]